Intra-Cellular Therapies Overview

Intra-Cellular Therapies Profit Margin

Profitability ratio analysis for ITCI.

Quarterly Profit Margin

-8.48%

↑ 61.00% YoY

As of Dec 2024

Annual Profit Margin (TTM)

-10.97%

↑ 63.70% YoY

Trailing 12 months ending Dec 2024

Average Profit Margin (Comparison Companies)

Profit Margin History

Profit Margin Comparison

Annual Profit Margin Growth Rate (%)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin